WAT Waters Earnings and EPS analysis

?
Relative Growth: Rel. Growth: 53
Relative Strength: Rel. Strength: 70
Relative Valuation: Rel. Valuation: 13
Relative Profitability: Rel. Profitability: 41

EPS in 2026 (TTM): $4.03

Last Report Period Date: Jul 4, 2026

Based on the company's latest reports for July 2026, the current 12-month EPS is $4.03. Waters's earnings per share in 2025 was reported at $10.8, marking a rise from $10.75 in 2024. In the quarterly report ending on Jul 4, 2026, WAT's earnings per share amounted to -$1.39.

WAT earnings history

Historical annual and quarterly earnings per share (EPS) data for Waters
EPS (TTM)
$4.03
EPS Growth YoY (Quarterly)
-156.3%
EPS (Quarterly)
-$1.39
EPS Growth (Quarterly)
-59.8%

Waters had an yealy earnings per share of $10.8, showing a rise of 0.5% from $10.75 recorded in 2024. The quarterly earnings per share for the period ending Jul 4, 2026, was -$1.39, showing a 156.3% decline compared to the same quarter last year. The trailing twelve months EPS for WAT is $4.03 as of July 2026. Waters's full-year EPS for 2024 was $10.75, a 1.1% decline compared to the previous year.

WAT EPS vs price chart

WAT EPS growth history

Earnings per share growth rates over time
EPS Growth YoY (Quarterly)
-156.3%
EPS growth YoY
0.5%
EPS growth 3Y avg
-2.9%
EPS growth 5Y avg
5.2%

Waters has recorded a decline in earnings per share of 156.3% in the past 12 months (YoY, quarterly). During the past three years, WAT registered an average yearly EPS growth of -2.9%. Waters had an average annual EPS growth of 5.2% in the last five years. Over the last decade, WAT had an average annual earnings per share growth of 6.6%.

WAT Earnings Waterfall

Breakdown of revenue, profit and net income for Waters

WAT Earnings vs Peers

What are the earnings of WAT compared to its peers
Stock name Price to Earnings EPS grwoth 1Y EPS grwoth 3Y EPS grwoth 5Y
MTD Mettler-Toledo International Inc 31.38 3.7% 2.8% 10.8%
A Agilent Technologies Inc 31.8 3.4% 3.1% 14.5%
TMO Thermo Fisher Scientific Inc 33.8 7.2% 0% 2%
DHR Danaher Corp 38.73 -4.9% -19.7% 0.4%
GE General Electric Company 40.75 35.8% 447.4% 12.1%
BIO Bio-Rad Laboratories Inc - Class A 47.21 142.6% N/A -26.3%
WAT Waters Corp 101.91 0.5% -2.9% 5.2%
BRKR Bruker Corp N/A -119.7% N/A N/A
HBIO Harvard Bioscience Inc N/A -357.1% N/A N/A

All data is based on quarterly TTM periods, unless otherwise specified.